Lake Street Downgrades INVE to Hold, Sets $4 Target
Lake Street cut its rating on INVE to hold with a $4 target on June 25, 2026, a 56.25% upside from the current price.
Key Points
- Lake Street downgraded INVE to hold with a new price target of $4 on June 25, 2026.
- Lake Street's $4 price target implies 56.25% upside from Identiv, Inc.'s ($INVE) current $2.56 share price.
- Shares of INVE traded near $2.56 on Thursday, with insider selling by key executives noted.
- Institutional changes included Royce & Associates increasing its stake by 9.3% and Vanguard opening a new position.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Lake Street has downgraded its rating on INVE to a hold, setting a price target of $4. This change was made on June 25, 2026, by analyst Jaeson Schmidt. The stock traded near $2.56 on Thursday.
Other Institutional Activity in INVE
Several institutional investors have adjusted their positions in INVE. Royce & Associates increased its holdings by 100,436 shares, marking a 9.3% increase, and now holds 1,176,540 shares valued at approximately $4.35 million. Vanguard Capital Management opened a new position with 1,051,859 shares, valued at about $3.89 million. Meanwhile, Essex Investment Management added 12,923 shares, a 1.8% increase, ending with 736,608 shares worth $2.73 million. Harbert Fund Advisors reduced its stake by 49,789 shares, a 6.3% decrease, holding 735,768 shares valued at $2.72 million. Pillsbury Lake Capital significantly cut its holdings by 453,643 shares, a 48% decrease, leaving it with 491,657 shares valued at $1.82 million.
Identiv, Inc. Stock Down 7.2%
Shares of INVE traded around $2.56 on Thursday. The stock's recent performance has seen fluctuations, with institutional and insider activities potentially impacting its movements.
$INVE price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Insider Buying and Selling at Identiv, Inc.
Recent insider transactions at INVE have shown significant selling activity. Chief Financial Officer Edward Kirnbauer sold 1,133 shares at an average price of $4.05 on June 1, 2026. CEO Kirsten Newquist sold shares multiple times, including 6,360 shares at $3.68 on April 15, 2026, and 77,532 shares at $3.17 on March 2, 2026. However, on the same day, Newquist also bought 150,000 shares, indicating mixed insider sentiment.
Analysts Set New Price Targets
On June 25, 2026, Lake Street downgraded INVE to hold with a $4 price target. Previously, on May 14, 2026, Lake Street maintained a buy rating with a $6 target, while Craig-Hallum upheld a buy rating with a $7 target. The current consensus among analysts is mixed, with a range of buy and hold ratings reflecting varied expectations for INVE's performance.
Bottom Line
Lake Street's recent downgrade of INVE to hold with a $4 target reflects a cautious outlook. The stock's trading price and recent insider selling add context to this analyst action. Institutional investors are also adjusting their positions, highlighting the dynamic environment surrounding INVE. As always, remember that analyst ratings are one of many factors to consider when evaluating a stock.
Get Identiv, Inc. alerts
New 13F filings, insider trades, and analyst moves on $INVE, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.
